Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pyrimidine derivatives from Roche for psychotic disorders

May 26, 1997

5-HT reuptake inhibitors disclosed by NeuroSearch

May 26, 1997

MAO-A and/or MAO-B inhibitors described by Synthelabo

May 26, 1997

EAA antagonists reported by Pharmacia & Upjohn

May 26, 1997

FUB-181: Potent and selective H3 antagonist

May 23, 1997

OPC-14117 effective in mouse model of motor neuron disease

May 23, 1997

Cortex to evaluate CX-516 for the treatment of schizophrenia

May 23, 1997

Results from a comparative study of olanzapine and risperidone reported

May 22, 1997

First launch for Quadramet

May 22, 1997

NMDA antagonist/opiate combination provides superior analgesia to morphine alone

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...